Insider Transactions in Q4 2024 at Century Therapeutics, Inc. (IPSC)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 04
2024
|
Brent Pfeiffenberger President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
243,447
-16.55%
|
$243,447
$1.44 P/Share
|
|
Nov 04
2024
|
Adrienne Farid Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
1,033
-0.76%
|
$1,033
$1.23 P/Share
|
|
Nov 04
2024
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
283
-0.09%
|
$283
$1.23 P/Share
|
|
Nov 01
2024
|
Douglas Carr SVP Finance & Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
16,611
-4.97%
|
$16,611
$1.26 P/Share
|
|
Oct 14
2024
|
Morgan Conn Chief Finanical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,148
+50.0%
|
-
|
|
Oct 01
2024
|
Chad Cowan Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
74,376
+26.08%
|
-
|